Atlas Trials

Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY

Clinical trial NCT03029689 · COMPLETED

Trial details

NCT number
NCT03029689
Sponsor
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV
Start date
2017-07-28
Primary completion
2020-04-30
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.